Medicus Pharma Ltd
MDCX2.439USD
-0.131-5.09%
Market hours （ET）Quotes delayed by 15 min
32.73MMarket Cap
LossP/E TTM
More Details of Medicus Pharma Ltd Company
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The Company investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The Company is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.
Company Info
Ticker SymbolMDCX
Company nameMedicus Pharma Ltd
IPO dateOct 11, 2023
CEODr. Raza Bokhari, M.D.
Number of employees12
Security typeOrdinary Share
Fiscal year-endOct 11
Address100 King Street West
CityTORONTO
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeM5X 1A4
Phone17323003046
Websitehttps://medicuspharma.com/
Ticker SymbolMDCX
IPO dateOct 11, 2023
CEODr. Raza Bokhari, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
793.17K
--
Mr. James P. Quinlan
Mr. James P. Quinlan
Chief Financial Officer
Chief Financial Officer
129.15K
--
Ms. Carolyn F Bonner
Ms. Carolyn F Bonner
President
President
18.91K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Mr. Andrew A. Smith
Mr. Andrew A. Smith
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Edward J. Brennan, Jr., M.D.
Dr. Edward J. Brennan, Jr., M.D.
Chief Scientific Officer, Head of Research and Development Program
Chief Scientific Officer, Head of Research and Development Program
--
--
Mr. Frank W. Lavelle
Mr. Frank W. Lavelle
Independent Director
Independent Director
--
--
Dr. Sara R. May, Ph.D.
Dr. Sara R. May, Ph.D.
Director
Director
--
--
Mr. Barry Fishman, CPA
Mr. Barry Fishman, CPA
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
793.17K
--
Mr. James P. Quinlan
Mr. James P. Quinlan
Chief Financial Officer
Chief Financial Officer
129.15K
--
Ms. Carolyn F Bonner
Ms. Carolyn F Bonner
President
President
18.91K
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
1.25K
--
Mr. Andrew A. Smith
Mr. Andrew A. Smith
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Jul 19
Updated: Sat, Jul 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Velocity Fund Partners LP
18.29%
215 Capital Togo PHL Fund I, LP
12.55%
Interchange Capital Partners LLC
9.96%
Armistice Capital LLC
7.95%
Hathaway (John)
5.03%
Other
46.23%
Shareholders
Shareholders
Proportion
Velocity Fund Partners LP
18.29%
215 Capital Togo PHL Fund I, LP
12.55%
Interchange Capital Partners LLC
9.96%
Armistice Capital LLC
7.95%
Hathaway (John)
5.03%
Other
46.23%
Shareholder Types
Shareholders
Proportion
Corporation
30.84%
Individual Investor
13.82%
Investment Advisor
11.73%
Hedge Fund
7.95%
Other
35.66%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
21
10.18M
63.87%
+72.74K
2025Q1
19
10.07M
84.39%
+1.61M
2024Q4
12
8.43M
77.76%
+1.48M
2024Q3
8
6.05M
68.59%
+2.33M
2024Q2
7
4.05M
50.15%
+329.10K
2024Q1
9
3.82M
47.35%
+3.82M
2023Q4
9
3.82M
47.35%
+3.82M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Velocity Fund Partners LP
2.91M
18.29%
+75.00K
+2.64%
Jun 02, 2025
215 Capital Togo PHL Fund I, LP
2.00M
12.55%
--
--
Jun 02, 2025
Interchange Capital Partners LLC
1.66M
10.43%
+204.71K
+14.05%
Mar 31, 2025
Armistice Capital LLC
1.27M
7.95%
--
--
Jun 02, 2025
Hathaway (John)
800.95K
5.03%
--
--
Jun 02, 2025
Bokhari (Raza)
793.17K
4.98%
--
--
Jun 02, 2025
Melani (Kenneth)
334.41K
2.1%
-75.00K
-18.32%
Jun 02, 2025
Quinlan (James P)
129.15K
0.81%
--
--
Jun 02, 2025
Brennan (Edward Joseph JR)
86.50K
0.54%
--
--
Jun 02, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
